Bosnia and Herzegovina - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)

Since 2014, Bosnia and Herzegovina Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) grew 3.5% year on year. In 2019, the country was number 21 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) with €42.68 Per Capita. Bosnia and Herzegovina is overtaken by Bulgaria, which was ranked number 20 at €56.11 Per Capita and is followed by Spain at €10.47 Per Capita. Switzerland ranked the highest with €665.57 Per Capita in 2019, that is +3.2% compared to 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal witnessed the worst performance at -12.9% per year.

Loading...

Date Euros Per Capita
2019 42.68
2018 42.06
2017 42.34
2016 42.75
2015 39.51
Download all data from 2013 to 2019

How does Bosnia and Herzegovina rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?

# 23 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
665.57 2019 +3.1 % +5.3 % View data
2 #2
Germany
524.79 2019 +2.3 % +3.0 % View data
20 #20
Bulgaria
56.11 2019 -0.3 % +4.1 % View data
21 #21
Bosnia and Herzegovina
42.68 2019 +1.5 % +3.5 % View data
22 #22
Spain
10.47 2019 +0.3 % +0.8 % View data
Compare all 23 countries

Go Top